These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 9592290)

  • 21. Diagnosis of oral premalignant and malignant lesions using cytomorphometry.
    Ramaesh T; Mendis BR; Ratnatunga N; Thattil RO
    Odontostomatol Trop; 1999 Mar; 22(85):23-8. PubMed ID: 11372099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphometric analysis of spinous cell in oral submucous fibrosis. Comparison with normal mucosa, leukoplakia and squamous cell carcinoma.
    Gao S; Liu S; Shen Z; Peng L
    Chin Med J (Engl); 1995 May; 108(5):351-4. PubMed ID: 7555236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
    van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
    Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
    Johnstone S; Logan RM
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
    Li SX; Yu SF; Sun KH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification.
    Acay R; Rezende N; Fontes A; Aburad A; Nunes F; Sousa S
    Oral Microbiol Immunol; 2008 Aug; 23(4):271-4. PubMed ID: 18582325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
    Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
    Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ].
    Babichenko II; Grigor'ian AS; Katushkina AA
    Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma.
    Etemad-Moghadam S; Khalili M; Tirgary F; Alaeddini M
    J Oral Pathol Med; 2009 Sep; 38(8):639-43. PubMed ID: 19473444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
    Girod SC; Kühnast T; Ulrich S; Krueger GR
    In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of epithelial cell activity in patients with oral cancer.
    Thomson PJ; Potten CS; Appleton DR
    Br J Oral Maxillofac Surg; 1999 Oct; 37(5):384-90. PubMed ID: 10577753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphological classification of oral leukoplakia (author's transl)].
    Burkhardt A; Seifert G
    Dtsch Med Wochenschr; 1977 Feb; 102(7):223-9. PubMed ID: 836383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of TC21 overexpression in oral cancer.
    Macha MA; Matta A; Sriram U; Thakkar A; Shukla NK; Datta Gupta S; Ralhan R
    J Oral Pathol Med; 2010 Jul; 39(6):477-85. PubMed ID: 20040018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation.
    Pandey M; Prakash O; Santhi WS; Soumithran CS; Pillai RM
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):379-83. PubMed ID: 18356024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changes of cytokeratin 19 during oral carcinogenesis.
    Nie M; Zhong L; Zeng G; Li B
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 May; 37(3):187-90. PubMed ID: 12419140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
    Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
    J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.